Pharmaceutical giant Pfizer will stop research on Alzheimer’s and Parkinson’s disease, and is expected to lay-off 300 research and development staff in Massachusetts and Connecticut, in a move that could severely hamper progress towards effective treatments for these illnesses – proving that critical medical research cannot be left in the hands of capitalist profiteers.